Collectively, these data demonstrate that HDAC1/2 are regulated by the Hh signaling to support tumor cell proliferation and argue that a selective pharmacological targeting of these deacetylases may counteract SHH-MB growth. The gene discussed is HDAC1; the disease is neoplasm.